Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects

被引:113
作者
Gao, Kai [1 ,2 ]
Li, Mengxin [1 ,3 ,4 ]
Zhong, Li [1 ,3 ,5 ]
Su, Qin [1 ,3 ]
Li, Jia [1 ,4 ]
Li, Shaoyong [1 ,4 ]
He, Ran [1 ,3 ]
Zhang, Yu [1 ,6 ]
Hendricks, Gregory [7 ]
Wang, Junzhi [2 ]
Gao, Guangping [1 ,3 ,4 ,8 ]
机构
[1] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA 01655 USA
[2] Natl Inst Food & Drug Control, Beijing, Peoples R China
[3] Univ Massachusetts, Sch Med, Viral Vector Core, Worcester, MA USA
[4] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA
[5] Univ Massachusetts, Sch Med, Dept Pediat, Div Hematol Oncol, Worcester, MA USA
[6] Guizhou Peoples Hosp, Dept Oncol, Guiyang, Guizhou, Peoples R China
[7] Univ Massachusetts, Sch Med, Electron Microscopy Core Facil, Dept Cell & Dev Biol, Worcester, MA USA
[8] Sichuan Univ, West China Hosp, Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
基金
美国国家卫生研究院;
关键词
CAPSID ANTIGEN PRESENTATION; GENE-TRANSFER; ANALYTICAL ULTRACENTRIFUGATION; FACTOR-IX; IN-VIVO; VIRUS; MICE; HEMOPHILIA; TISSUE; ADENOVIRUS;
D O I
10.1038/mtm.2013.9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Empty virions are inadvertent by-products of recombinant adeno-associated virus (rAAV) packaging process, resulting in vector lots with mixtures of full and empty virions at variable ratios. Impact of empty virions on the efficiency and side effects of rAAV transduction has not been well characterized. Here, we generated partially and completely empty AAV8 virions, fully packaged rAAV8 lots, and mixtures of empty and fully packaged virions with variable ratios of empty virions. The aforementioned dosing formulations of rAAV8 expressing either cellular (EGFP (enhanced green fluorescent protein) or nuclear-targeted (n) LacZ) or secreted (human a1-antitrypsin (hA1AT)) reporter genes were intravenously injected into two different mouse strains, followed by analyses of transgene expressions and serum alanine aminotransferase (ALT) levels at different time points. We found that addition of empty particles to the fixed doses of rAAV8 preparations repressed liver transduction up to 64% (serum hA1AT) and 44% (nLacZ) in C57BL/6 mice, respectively. The similar trend in inhibiting EGFP expression together with concurrent elevations of serum ALT levels were observed in the BALB/c mice, indicating that empty particles may also exacerbate side effects of rAAV8 EGFP transduction. Our results suggest that removal of empty particles from rAAV preparations may improve efficacy and safety of AAV in clinical applications.
引用
收藏
页数:8
相关论文
共 31 条
  • [1] Ahmed Seemin Seher, 2013, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14d06s29
  • [2] A Single Intravenous rAAV Injection as Late as P20 Achieves Efficacious and Sustained CNS Gene Therapy in Canavan Mice
    Ahmed, Seemin Seher
    Li, Huapeng
    Cao, Chunyan
    Sikoglu, Elif M.
    Denninger, Andrew R.
    Su, Qin
    Eaton, Samuel
    Navarro, Ana A. Liso
    Xie, Jun
    Szucs, Sylvia
    Zhang, Hongwei
    Moore, Constance
    Kirschner, Daniel A.
    Seyfried, Thomas N.
    Flotte, Terence R.
    Matalon, Reuben
    Gao, Guangping
    [J]. MOLECULAR THERAPY, 2013, 21 (12) : 2136 - 2147
  • [3] Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial
    Allay, James A.
    Sleep, Susan
    Long, Scott
    Tillman, David M.
    Clark, Rob
    Carney, Gael
    Fagone, Paolo
    McIntosh, Jenny H.
    Nienhuis, Arthur W.
    Davidoff, Andrew M.
    Nathwani, Amit C.
    Gray, John T.
    [J]. HUMAN GENE THERAPY, 2011, 22 (05) : 595 - 604
  • [4] [Anonymous], 2012, MOL CLONING
  • [5] High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency
    Ayuso, E.
    Mingozzi, F.
    Montane, J.
    Leon, X.
    Anguela, X. M.
    Haurigot, V.
    Edmonson, S. A.
    Africa, L.
    Zhou, S.
    High, K. A.
    Bosch, F.
    Wright, J. F.
    [J]. GENE THERAPY, 2010, 17 (04) : 503 - 510
  • [6] No evidence for tumorigenesis of AAV vectors in a large-scale study in mice
    Bell, P
    Wang, LL
    Lebherz, C
    Flieder, DB
    Bove, MS
    Wu, D
    Gao, GP
    Wilson, JM
    Wivel, NA
    [J]. MOLECULAR THERAPY, 2005, 12 (02) : 299 - 306
  • [7] Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver
    Bell, Peter
    Moscioni, A. David
    McCarter, Robert J.
    Wu, Di
    Gao, Guangping
    Hoang, Albert
    Sanmiguel, Julio C.
    Sun, Xun
    Wivel, Nelson A.
    Raper, Steven E.
    Furth, Emma E.
    Batshaw, Mark L.
    Wilson, James M.
    [J]. MOLECULAR THERAPY, 2006, 14 (01) : 34 - +
  • [8] BALB/c Mice Show Impaired Hepatic Tolerogenic Response Following AAV Gene Transfer to the Liver
    Breous, Ekaterina
    Somanathan, Suryanarayan
    Wilson, James M.
    [J]. MOLECULAR THERAPY, 2010, 18 (04) : 766 - 774
  • [9] Hepatic Regulatory T Cells and Kupffer Cells Are Crucial Mediators of Systemic T Cell Tolerance to Antigens Targeting Murine Liver
    Breous, Ekaterina
    Somanathan, Suryanarayan
    Vandenberghe, Luk H.
    Wilson, James M.
    [J]. HEPATOLOGY, 2009, 50 (02) : 612 - 621
  • [10] Analytical ultracentrifugation: Sedimentation velocity and sedimentation equilibrium
    Cole, James L.
    Lary, Jeffrey W.
    Moody, Thomas P.
    Laue, Thomas M.
    [J]. BIOPHYSICAL TOOLS FOR BIOLOGISTS: VOL 1 IN VITRO TECHNIQUES, 2008, 84 : 143 - 179